Related Experiment Video
Updated: Dec 11, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Contemporary Surgical and Transcatheter Management of Mitral Annular Calcification
J James Edelman1, Vinay Badhwar2, Robert Larbalestier1
1Department of Cardiothoracic Surgery and Transplantation, Fiona Stanley Hospital, Perth, Australia.
Insights
Mitral annular calcification (MAC) complicates mitral valve (MV) disease management. This review covers surgical and transcatheter techniques for MAC, offering options for high-risk patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Cardiac Surgery
Background:
- Mitral annular calcification (MAC) presents challenges in managing mitral valve (MV) stenosis or regurgitation.
- Patients with MAC often have comorbidities, limiting surgical candidacy.
- This review focuses on contemporary techniques for managing MAC during MV treatment.
Purpose of the Study:
- To review the anatomy, pathology, and management of MAC in patients with severe MV disease.
- To highlight current surgical and transcatheter techniques for MAC treatment.
- To discuss the outcomes associated with various MAC management strategies.
Main Methods:
- Focused review of existing literature on MAC.
- Description of surgical approaches for MAC resection (en bloc vs. incomplete).
- Evaluation of transcatheter techniques and their limitations in MAC patients.
Main Results:
- MAC incidence ranges from 5% to 42% in severe MV disease.
- Pathophysiology likely involves inflammation and atherosclerosis.
- Transcatheter therapies face challenges like left ventricular outflow tract obstruction and paravalvular regurgitation.
Conclusions:
- A range of techniques exists for managing MAC in severe MV disease.
- Transcatheter therapies expand options for patients with high surgical risk.
Background:
The presence of mitral annular calcification (MAC) in patients with mitral valve (MV) stenosis or regurgitation is a difficult scenario for surgeons and the heart team. Patients with MAC most often have a significant number of comorbidities that exclude them as surgical candidates. This review highlights the various contemporary techniques available to manage MAC during treatment of the MV.
Methods:
This study is a focused review of the anatomy, pathology, and management of MAC. The review describes the surgical and transcatheter techniques with outcomes, where available.
Results:
The incidence of MAC is between 5% and 42% in patients with severe MV disease. The pathophysiology underlying MAC is not yet clear, but it most likely is related to processes of inflammation and atherosclerosis. Surgical techniques can be grouped into those in which the MAC is completely resected en bloc and those in which the MAC is incompletely resected or left in situ. Transcatheter therapies are feasible in some patients, but they have been limited by the anatomic constraints of MAC; most importantly left ventricular outflow tract obstruction and paravalvular regurgitation.
Conclusions:
Surgeons as part of the heart team now have a range of techniques to manage MAC in those patients with severe MV disease. Transcatheter therapies may increase the options for patients whose surgical risk is too high.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse III: Nursing Management

